Challenges and Future of Drug-Induced Liver Injury Research—Laboratory Tests
Drug-induced liver injury (DILI) is a rare but potentially severe adverse drug event, which is also a major cause of study cessation and market withdrawal during drug development. Since no acknowledged diagnostic tests are available, DILI diagnosis poses a major challenge both in clinical practice a...
Main Authors: | Sabine Weber, Alexander L. Gerbes |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/11/6049 |
Similar Items
-
Drug-induced liver injury: An overview and update
by: Yujie Wang, et al.
Published: (2023-04-01) -
Drug-induced liver injury in association with antipsychotics
by: R. Zeiss, et al.
Published: (2022-06-01) -
Drug-induced liver injury secondary to turmeric use
by: Ashika Ajitkumar, et al.
Published: (2023-04-01) -
Drug-induced cholestasis: causative agents and challenges in diagnosis and management
by: Jose M. Pinazo-Bandera, et al.
Published: (2023-09-01) -
Drug-induced liver injury in Switzerland: an analysis of drug-related hepatic disorders in the WHO pharmacovigilance database VigiBase™ from 2010 to 2020
by: Imke Ortland, et al.
Published: (2021-05-01)